301 related articles for article (PubMed ID: 27909988)
1. Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.
Aarde SM; Taffe MA
Curr Top Behav Neurosci; 2017; 32():145-164. PubMed ID: 27909988
[TBL] [Abstract][Full Text] [Related]
2. Intravenous self-administration of entactogen-class stimulants in male rats.
Vandewater SA; Creehan KM; Taffe MA
Neuropharmacology; 2015 Dec; 99():538-45. PubMed ID: 26302654
[TBL] [Abstract][Full Text] [Related]
3. Intravenous self-administration of mephedrone, methylone and MDMA in female rats.
Creehan KM; Vandewater SA; Taffe MA
Neuropharmacology; 2015 May; 92():90-7. PubMed ID: 25600245
[TBL] [Abstract][Full Text] [Related]
4. The preclinical pharmacology of mephedrone; not just MDMA by another name.
Green AR; King MV; Shortall SE; Fone KC
Br J Pharmacol; 2014 May; 171(9):2251-68. PubMed ID: 24654568
[TBL] [Abstract][Full Text] [Related]
5. Reinforcing Effects of Cathinone NPS in the Intravenous Drug Self-Administration Paradigm.
Watterson LR; Olive MF
Curr Top Behav Neurosci; 2017; 32():133-143. PubMed ID: 27431398
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.
Harvey EL; Baker LE
Psychopharmacology (Berl); 2016 Feb; 233(4):673-80. PubMed ID: 26558618
[TBL] [Abstract][Full Text] [Related]
7. Discriminative-Stimulus Effects of Synthetic Cathinones in Squirrel Monkeys.
Wakeford AGP; Sherwood AM; Prisinzano TE; Bergman J; Kohut SJ; Paronis CA
Int J Neuropsychopharmacol; 2021 Aug; 24(8):656-665. PubMed ID: 33909067
[TBL] [Abstract][Full Text] [Related]
8. MDMA: interactions with other psychoactive drugs.
Mohamed WM; Ben Hamida S; Cassel JC; de Vasconcelos AP; Jones BC
Pharmacol Biochem Behav; 2011 Oct; 99(4):759-74. PubMed ID: 21756931
[TBL] [Abstract][Full Text] [Related]
9. Escalation of intravenous self-administration of methylone and mephedrone under extended access conditions.
Nguyen JD; Grant Y; Creehan KM; Vandewater SA; Taffe MA
Addict Biol; 2017 Sep; 22(5):1160-1168. PubMed ID: 27046454
[TBL] [Abstract][Full Text] [Related]
10. Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy.
Oeri HE
J Psychopharmacol; 2021 May; 35(5):512-536. PubMed ID: 32909493
[TBL] [Abstract][Full Text] [Related]
11. Locomotor sensitization in male Sprague-Dawley rats following repeated concurrent treatment with 4-methylmethcathinone and 3,4-methylenedioxymethamphetamine.
Bullock TA; Berquist MD; Baker LE
Behav Pharmacol; 2019 Oct; 30(7):566-573. PubMed ID: 31268871
[TBL] [Abstract][Full Text] [Related]
12. Human Pharmacology of Mephedrone in Comparison with MDMA.
Papaseit E; Pérez-Mañá C; Mateus JA; Pujadas M; Fonseca F; Torrens M; Olesti E; de la Torre R; Farré M
Neuropsychopharmacology; 2016 Oct; 41(11):2704-13. PubMed ID: 27206266
[TBL] [Abstract][Full Text] [Related]
13. "Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.
Dolan SB; Chen Z; Huang R; Gatch MB
Neuropharmacology; 2018 May; 133():171-180. PubMed ID: 29378213
[TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats.
Huang PK; Aarde SM; Angrish D; Houseknecht KL; Dickerson TJ; Taffe MA
Drug Alcohol Depend; 2012 Nov; 126(1-2):168-75. PubMed ID: 22664136
[TBL] [Abstract][Full Text] [Related]
15. Behavioral profiles in rats distinguish among "ecstasy," methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for "ecstasy" analogues.
Quinteros-Muñoz D; Sáez-Briones P; Díaz-Véliz G; Mora-Gutiérrez S; Rebolledo-Fuentes M; Cassels BK
Behav Neurosci; 2010 Oct; 124(5):662-76. PubMed ID: 20939666
[TBL] [Abstract][Full Text] [Related]
16. Mephedrone and MDMA: A comparative review.
Mead J; Parrott A
Brain Res; 2020 May; 1735():146740. PubMed ID: 32087112
[TBL] [Abstract][Full Text] [Related]
17. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.
Baumann MH; Ayestas MA; Partilla JS; Sink JR; Shulgin AT; Daley PF; Brandt SD; Rothman RB; Ruoho AE; Cozzi NV
Neuropsychopharmacology; 2012 Apr; 37(5):1192-203. PubMed ID: 22169943
[TBL] [Abstract][Full Text] [Related]
18. Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine.
Muskiewicz DE; Resendiz-Gutierrez F; Issa O; Hall FS
Pharmacol Biochem Behav; 2020 Apr; 191():172871. PubMed ID: 32061662
[TBL] [Abstract][Full Text] [Related]
19. Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats.
Motbey CP; Hunt GE; Bowen MT; Artiss S; McGregor IS
Addict Biol; 2012 Mar; 17(2):409-22. PubMed ID: 21995495
[TBL] [Abstract][Full Text] [Related]
20. Instability of the ecstasy market and a new kid on the block: mephedrone.
Brunt TM; Poortman A; Niesink RJ; van den Brink W
J Psychopharmacol; 2011 Nov; 25(11):1543-7. PubMed ID: 20826554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
